SOPHIA ANTIPOLIS, France–( SERVICE CORD)– Regulatory Information: Average Technologies (FR0011049824, ALMDT, PEA/PME system eligible, “Average” or “The Firm”), supplier of eyonis ™, a collection of expert system (AI) powered Software application as a Clinical Tool (SaMD) for very early cancer cells medical diagnosis, and a worldwide leading carrier of AI-based picture evaluations and main imaging solutions for oncology medicine designers, launches today its Q1 2025 vital economic signs (unaudited) and offers an upgrade on
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/median-technologies-reports-2025-q1-key-financial-indicators-and-provides-an-update-on-q1-key-operational-achievements/
